The impact of pre-existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults

被引:2
|
作者
Kang, Min [1 ,2 ]
Lin, Fangmei [3 ,4 ,5 ]
Jiang, Zhanpeng [3 ,4 ,5 ]
Tan, Xiaohua [2 ]
Lin, Xia [3 ,4 ,5 ]
Liang, Zaolan [3 ,4 ,5 ,6 ]
Xiao, Cheng [3 ,4 ,5 ,6 ]
Xia, Yonghe [7 ]
Guan, Wenda [4 ,5 ,8 ]
Yang, Zifeng [4 ,5 ,8 ]
Yu, Guangchuang [9 ]
Zanin, Mark [10 ,11 ]
Tang, Shixing [1 ,13 ]
Wong, Sook-San [6 ,10 ,12 ]
机构
[1] Southern Med Univ, Sch Publ Hlth, Guangzhou, Peoples R China
[2] Guangdong Ctr Dis Control & Prevent, Guangzhou, Peoples R China
[3] Guangzhou Med Univ, Guangzhou, Peoples R China
[4] State Key Lab Resp Dis, Guangzhou, Peoples R China
[5] Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China
[6] Univ Hong Kong, Sch Publ Hlth, LKS Fac Med, HKU Pasteur Res Pole, Hong Kong, Peoples R China
[7] Zhongshan Yiyan Biopharmaceut Co Ltd, Zhongshan, Peoples R China
[8] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Natl Ctr Resp Med, Guangzhou, Peoples R China
[9] Southern Med Univ, Sch Basic Med Sci, Dept Bioinformat, Guangzhou, Peoples R China
[10] Univ Hong Kong, Sch Publ Hlth, LKS Fac Med, Hong Kong, Peoples R China
[11] Ctr Immunol & Infect, Shatin, Hong Kong, Peoples R China
[12] Univ Hong Kong, Sch Publ Hlth, LKS Fac Med, Pasteur Res Pole,Pokfulam, 5 Sassoon Rd, Hong Kong, Peoples R China
[13] Southern Med Univ, Sch Publ Hlth, 1023-1063 Shatai South Rd, Guangzhou 510515, Peoples R China
关键词
antibodies; cytokines; influenza; older adults; vaccines; FRAILTY;
D O I
10.1111/irv.13172
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Age-associated immune changes and pre-existing influenza immunity are hypothesized to reduce influenza vaccine effectiveness in older adults, although the contribution of each factor is unknown. Here, we constructed influenza-specific IgG landscapes and determined baseline concentrations of cytokines typically associated with chronic inflammation in older adults (TNF-& alpha;, IL-10, IL-6, and IFN-& gamma;) in 30 high and 29 low influenza vaccine responders (HR and LR, respectively). In a background of high H3 antibody titers, vaccine-specific H3, but not H1, antibody titers were boosted in LRs to titers comparable to HRs. Pre-vaccination concentrations of IL-10 were higher in LRs compared with HRs and inversely correlated with titers of pre-existing influenza antibodies. Baseline TNF-& alpha; concentrations were positively correlated with fold-increases in antibody titers in HRs. Our findings indicate that baseline inflammatory status is an important determinant for generating post-vaccination hemagglutinin-inhibition antibodies in older adults, and IgG responses can be boosted in the context of high pre-existing immunity.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Immunogenicity and Reactogenicity of a Monovalent Inactivated 2009 Influenza A Vaccine in Adolescents: With Special Reference to Pre-Existing Antibody
    Kobayashi, Masayuki
    Ohfuji, Satoko
    Fukushima, Wakaba
    Maeda, Akiko
    Maeda, Kazuhiro
    Fujioka, Masashi
    Hirota, Yoshio
    JOURNAL OF PEDIATRICS, 2012, 160 (04): : 632 - +
  • [22] The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial
    Martin, Dominique E.
    Cadar, Andreia N.
    Panier, Hunter
    Torrance, Blake L.
    Kuchel, George A.
    Bartley, Jenna M.
    IMMUNITY & AGEING, 2023, 20 (01)
  • [23] The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial
    Dominique E. Martin
    Andreia N. Cadar
    Hunter Panier
    Blake L. Torrance
    George A. Kuchel
    Jenna M. Bartley
    Immunity & Ageing, 20
  • [24] Pre-existing immunity to influenza aids ferrets in developing stronger and broader H3 vaccine-induced antibody responses
    Ge, Yang
    Lu, Yao
    Allen, James D.
    Einav, Tal
    Nkaleke, Dennis I.
    Bai, Fengwei
    Handel, Andreas
    Ross, Ted M.
    Shen, Ye
    VACCINE, 2024, 42 (21)
  • [25] Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age
    Ross, Ted M.
    Lin, Chyongchiou Jeng
    Nowalk, Mary Patricia
    Huang, Hsin-Hui
    Spencer, Sarah M.
    Shay, David K.
    Sambhara, Suryaprakash
    Sundaram, Maria E.
    Friedrich, Thomas
    Sauereisen, Sandy
    Bloom, Chalise E.
    Zimmerman, Richard K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1195 - 1203
  • [26] Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children
    Cole, M. E.
    Kundu, R.
    Abdulla, A. F.
    Andrews, N.
    Hoschler, K.
    Southern, J.
    Jackson, D.
    Miller, E.
    Zambon, M.
    Turner, P. J.
    Tregoning, J. S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 204 (01): : 125 - 133
  • [27] Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications
    Boikos, Constantina
    Imran, Mahrukh
    Nguyen, Van Hung
    Ducruet, Thierry
    Sylvester, Gregg C.
    Mansi, James A.
    VACCINES, 2021, 9 (08)
  • [28] Pre-existing immunity in human challenge studies of influenza transmission Reply
    Killingley, Ben
    Hayward, Andrew
    Enstone, Joanne E.
    Ferguson, Neil
    Oxford, John
    Nguyen-Van-Tam, Jonathan
    Booy, Robert
    LANCET INFECTIOUS DISEASES, 2012, 12 (10): : 744 - 745
  • [29] Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial
    Kang, Kyuri
    Han, Seunghoon
    Hong, Taegon
    Jeon, Sangil
    Paek, Jeongki
    Kang, Jin Han
    Yim, Dong-Seok
    YONSEI MEDICAL JOURNAL, 2016, 57 (06) : 1354 - 1360
  • [30] Inactivated influenza vaccine does not reduce all cause respiratory illness in children with pre-existing medical conditions
    de Hoog, Marieke L. A.
    Venekamp, Roderick P.
    Meijer, Adam
    Sanders, Elisabeth A. M.
    Bruijning-Verhagen, Patricia C. J. L.
    VACCINE, 2020, 38 (17) : 3397 - 3403